ALL (Aspirin, Lisinopril and Lipid-Lowering Medication) HEART
All HEART is a program targeted towards reducing heart attacks and strokes through the identification and treatment of diabetes and hypertension using evidence based guidelines among the safety-net population in community health centers in Southern California.
Since 2003, Kaiser Permanente has implemented innovative cardiovascular disease risk reduction clinic practices in California that emphasize the use of cardioprotective medications in individuals at high risk of experiencing heart attacks and strokes. Based on the success of these practices, Kaiser Permanente Southern California Region Community Benefit began to support the translation of these practices to safety net providers.
Kaiser Permanente’s ALL initiative (Aspirin, Lisinopril and Lipid-lowering medication) was implemented to reduce heart attacks and strokes by aggressively enrolling patients with heart disease or patients who are at least 55 years old with diabetes, in a therapeutic program that included the use of these three medications.
Research has shown that bundling two low-cost, generic heart drugs - a cholesterol-lowering statin and a blood pressure-lowering drug - prevents heart attack and stroke. Realizing the benefits for its members and community partners, Kaiser Permanente awarded Community Benefit grants to share this initiative with safety net health centers. Those grants led to the implementation of ALL in several health centers Southern California, and a similar initiative called PHASE in Northern California.
Patients based in community health centers in Southern California are the program's focus. In partnership with Kaiser Permanente, HQP has worked with several health centers and is currently expanding ALL HEART to additional health centers. While the focus to date has been on patients in community health centers with diabetes, in the 2016-2017 year funding cycle, HQP expanded focus to include hypertension. ALL HEART identifies health center patients ages 50 and over with diabetes and patients age 18 and over with hypertension.
ALL HEART currently has 10 participating health centers with 53 sites in 6 counties.